References
1 Meneses, A. 5‐HT system and cognition. Neurosci Biobehav Rev 1999, 23:1111–1125.
2 Jone, BJ, Blackburn, TP. The medical benefit of 5‐HT research. Pharmacol Biochem Behav 2002, 71: 555–568.
3 Hornung, JP. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003, 26:331–343.
4 Descarries, L, Watkins, KC, Garcia, S, Beaudet, A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J Comp Neurol 1982, 207:239–254.
5 Descarries, L, Riad, M, Parent, M. %22Ultrastructure of the serotonin innervation in the mammalian central nervous system.%22 In: Muller, CP, Jacobs, B, eds. Handbook of the Behavioural Neurobiology of Serotonin. Amsterdam:
Elsevier; 2009, 65–101.
6 IUPAHR Database. Available at: (August 2010 version). (Accessed April 3, 2011).
7 Raymond, JR, Mukhin, YV, Gettys, TW, Garnovskaya, MN. The recombinant 5‐HT1A receptor: G protein coupling and signalling pathways. Br J Pharmacol 1999, 127:1751–1764.
8 Harrington, MA, Oksenberg, D, Peroutka, SJ. 5‐Hydro xytryptamine1A receptors are linked to a Gi‐adenylate cyclase complex in rat hippocampus. Eur J Pharmacol 1988, 154:95–98.
9 Albert, PR, Zhou, QY, Van Tol, HH, Bunzow, JR, Civelli, O. Cloning, functional expression, and mRNA tissue distribution of the rat 5‐hydroxytryptamine1A receptor gene. J Biol Chem 1990, 265:5825–5832.
10 Raymond, JR, Mukhin, YV, Gelasco, A, Turner, J, Collinsworth, G, Gettys, TW, Grewal, JS, Garnovskaya, MN. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 2001, 92:179–212.
11 Marcinkiewicz, M, Vergé, D, Gozlan, H, Pichat, L, Hamon, M. Autoradiographic evidence for the heterogeneity of 5‐HT1 sites in the rat brain. Brain Res 1984, 291:159–163.
12 Sprouse, JS, Aghajanian, GK. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists. Synapse 1987, 1:3–9.
13 Kia, HK, Miquel, MC, Brisorgueil, MJ, Daval, G, El Mestikawy, S, Riad, M, Hamon, M, Vergé, D. Immunocytochemical localization of 5‐HT1A receptors in the rat central nervous system. J Comp Neurol 1996, 365:289–305.
14 Lanfumey, L, Hamon, M. 5‐HT1 receptors. Curr Drug Targets CNS Neurol Disord 2004, 3:1–10.
15 Borg, J. Molecular imaging of the 5‐HT(1A) receptor in relation to human cognition. Behav Brain Res 2008, 195:103–111.
16 Blier, P, de Montigny, C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994, 15:220–226.
17 Piñeyro, G, Blier, P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Reviews 1999, 51:533–591.
18 Heisler, LK, Chu, HM, Brennan, TJ, Danao, JA, Bajwa, P, Parsons, LH, Tecott, LH. Elevated anxiety and antidepressant‐like responses in serotonin 5‐HT1A receptor mutant mice. Proc Natl Acad Sci U S A 1998, 95:15049–15054.
19 Parks, CL, Robinson, PS, Sibille, E, Shenk, T, Toth, M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Nat Acad Sci U S A 1998, 95:10734–10739.
20 Ramboz, S, Oosting, R, Amara, DA, Kung, HF, Blier, P, Mendelsohn, M, Mann, JJ, Brunner, D, Hen, R. Serotonin receptor 1A knockout: an animal model of anxiety‐related disorder. Proc Natl Acad Sci U S A 1998, 95:14476–14481.
21 Richardson‐Jones, JW, Craige, CP, Guiard, BP, Stephen, A, Metzger, KL, Kung, HF, Gardier, AM, Dranovsky, A, David, DJ, Beck, SG, et al. 5‐HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65:40–52.
22 Le François, B, Czesak, M, Steubl, D, Albert, PR. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008, 55:977–985.
23 El Mestikawy, S, Riad, M, Laporte, AM, Vergé, D, Daval, G, Gozlan, H, Hamon, M. Production of specific anti‐rat 5‐HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci Lett 1990, 118:189–192.
24 Riad, M, Garcia, S, Watkins, KC, Jodoin, N, Doucet, E, Langlois, X, El Mestikawy, S, Hamon, M, Descarries, L. Somatodendritic localization of 5‐HT1A and preterminal axonal localization of 5‐HT1B serotonin receptors in adult rat brain. J Comp Neurol 2000, 417:181–194.
25 Riad, M, Watkins, KC, Doucet, E, Hamon, M, Descarries, L. Agonist‐induced internalization of serotonin‐1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci 2001, 21:8378–8386.
26 Zimmer, L, Riad, M, Rbah, L, Belkacem‐Kahlouli, A, Le Bars, D, Renaud, B, Descarries, L. Toward brain imaging of serotonin 5‐HT1A autoreceptor internalization. NeuroImage 2004, 22:1421–1426.
27 Beer, M, Kennett, GA, Curzon, G. A single dose of 8‐OH‐DPAT reduces raphe binding of [
3H]8‐OH‐DPAT and increases the effect of raphe stimulation on 5‐HT metabolism. Eur J Pharmacol 1990, 178:179–187.
28 La Cour, CM, El Mestikawy, S, Hanoun, N, Hamon, M, Lanfumey, L. Regional differences in the coupling of 5 hydroxytryptamine‐1A receptors to G proteins in the rat brain. Mol Pharmacol 2006, 70:1013–1021.
29 Riad, M, Zimmer, L, Rbah, L, Watkins, KC, Hamon, M, Descarries, L. Acute treatment with the antidepressant fluoxetine internalizes 5‐HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [
18]MPPF in the nucleus raphe dorsalis of rat. J Neurosci 2004, 24:5420–5426.
30 Riad, M, Rbah, L, Verdurand, M, Aznavour, N, Zimmer, L, Descarries, L. Unchanged density of 5‐HT1A autoreceptors on the plasma membrane of nucleus raphe dorsalis neurons in rats chronically treated with fluoxetine. Neuroscience 2008, 151:692–700.
31 Moulin‐Sallanon, M, Charnay, Y, Ginovart, N, Perret, P, Lanfumey, L, Hamon, M, Hen, R, Fagret, D, Ibanez, V, Millet, P. Acute and chronic effects of citalopram on 5‐HT
1A receptor‐labeling by [
18F]MPPF and coupling to receptors‐G proteins. Synapse 2009, 63:106–116.
32 Aznavour, N, Rbah, L, Riad, M, Reilhac, A, Costes, N, Descarries, L, Zimmer, , L. A PET imaging study of 5‐HT1A receptors in cat brain after acute and chronic fluoxetine treatment. NeuroImage 2006, 33:834–842.
33 Sibon, I, Benkelfat, C, Gravel, P, Aznavour, N, Costes, N, Mzengeza, S, Booij, L, Baker, G, Soucy, J‐P, Zimmer, L, et al. Decreased [
18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a PET study in healthy volunteers. Biol Psychiatry 2008, 63:1135–1140.
34 Savitz, J, Lucki, I, Drevets, WC. 5‐HT1A receptor function in major depressive disorder. Prog Neurobiol 2009, 88:17–31.
35 Rush, AJ, Trivedi, MH, Wisniewski, SR, Nierenberg, AA, Stewart, JW, Warden, D, Niederehe, G, Thase, ME, Lavori, PW, Lebowitz, BD, et al. Acute and longer‐term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163:1905–1917.
36 Stockmeier, CA, Shapiro, LA, Dilley, GE, Kolli, TN, Friedman, L, Rajkowska, G. Increase in serotonin‐1A autoreceptors in the midbrain of suicide victims with major depression—Postmortem evidence for decreased serotonin activity. J Neurosci 1998, 18:7394–7401.
37 Parsey, RV, Oquendo, MA, Ogden, RT, Olvet, DM, Simpson, N, Huang, YY, Van Heertum, RL, Arango, V, Mann, JJ. Altered serotonin 1A binding in major depression: a [carbonyl‐C‐11]WAY100635 positron emission tomography study. Biol Psychiatry 2006, 59:106–113.
38 Parsey, RV, Ogden, RT, Miller, JM, Tin, A, Hesselgrave, N, Goldstein, E, Mikhno, A, Milak, M, Zanderigo, F, Sullivan, GM, et al. Higher serotonin 1A binding in a second major depression cohort: Modeling and reference region considerations. Biol Psychiatry 2010, 68:170–178.
39 Kishi, T, Tsunoka, T, Ikeda, M, Kawashima, K, Okochi, T, Kitajima, T, Kinoshita, Y, Okumura, T, Yamanouchi, Y, Inada, T, et al. Serotonin 1A receptor gene and major depressive disorder: an association study and meta‐analysis. J Hum Genet 2009, 54:629–633.